Annual Drug Patent Expirations for ONIVYDE
Onivyde is a drug marketed by Ipsen Inc and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug.
This drug has ninety-three patent family members in twenty-five countries.
The generic ingredient in ONIVYDE is irinotecan hydrochloride. One supplier is listed for this compound. Additional details are available on the irinotecan hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
